ATCC and the Association of Biomolecular Resource Facilities Metagenomics Research Group (ABRF-MGRG) announce the launch of three new microbiome reference standards comprising genomic DNA prepared from microorganisms prevalent in extreme environments.
ATCC announces the release of an innovative, in vitro model system for a key mechanism of invasion and metastasis in lung cancer.
During Association of Molecular Pathology (AMP) conference subject matter experts from ATCC emphasize the importance and need for consistent, reliable standards for next-generation sequencing.
ATCC announces two appointments to the senior leadership team. Mr. Daniel Kelly joins ATCC as Chief Information and Technology Officer (CITO), and Mr. John Sweeney joins as Chief Financial Officer (CFO).
ATCC, in partnership with the Institute for Life Science Entrepreneurship (ILSE) and the ATCC Center for Translational Microbiology (ATCC-CTM), announces the launch of the ATCC Global Priority Superbugs collection.
ATCC and One Codex announce the formation of a partnership to address microbiome research needs.
Subject matter experts from ATCC partner with The Michael J. Fox Foundation for Parkinson’s Research (MJFF) to facilitate a corporate workshop at the International Society for Biological and Environmental Repositories (ISBER) 2017 Annual Meeting.
ATCC's new cGMP-compliant biorepository is dedicated to the storage, distribution, and management of cell lines and other biomaterials for a wide variety of customers including vaccine, biotechnology and pharmaceutical companies, clinical laboratories, academic institutions, foundations, and federal agencies.
The National Cancer Institute (NCI) awards ATCC a five-year indefinite-delivery/indefinite-quantity (IDIQ) contract to support the Division of Cancer Epidemiology and Genetics’ (DCEG) Molecular Epidemiology Assay Support (MEAS) program.